FRI congratulates Dr. Frank Vocci, Co-Investigator of the study “A Human Abuse Potential Study of Kratom” with Dr. Christopher Verrico at Baylor College of Medicine, on the feature of their research in Bloomberg News. Click here to read the article.
FRI congratulates Dr. Mishka Terplan, who will now serve as a full Editorial Board member for Drug and Alcohol Dependence Reports, after providing outstanding service as an Editorial Board Associate.
FRI is pleased to announce that Dr. Karli R Hochstatter has received an R21 award from the National Institute on Drug Abuse through the HEAL Initiative, titled “Leveraging a time-limited opportunity to study the impact of an intervention for individuals bereaved by drug overdose.” Co-investigators include Drs. Jan Gryczynski and Karen Alexander. This study is in collaboration with New […]
FRI is pleased to announce that Dr. Ginnie Sawyer-Morris has received a diversity supplement from the National Institute on Drug Abuse entitled, “Use of topic modeling and stakeholder engagement to map determinants of implementation disparities in addiction and pain research.” This supplement is an extension of the NIDA-funded HD2A Research Adoption Support Center (RASC) at Stanford University […]
FRI is pleased to announce that Dr. Jan Gryczynski was selected to be FRI’s Vice President, effective November 27, 2024. In his role as Vice President, Dr. Gryczynski will join the President, Chief Operating Officer, and Medical Director on the Executive Management Committee, where he will contribute to organizational strategy and the development and execution of […]
Drs. Nikej Shah of Nirsum Labs and Frank Vocci of Friends Research Institute are Co-Principal Investigators of an NIH UG3/UH3 grant, “Development of a novel drug to treat opioid use disorder.” All IND-enabling studies have been completed and the Food and Drug Administration (FDA) granted an IND to Nirsum to proceed to Phase I trials. […]
FRI is pleased to announce that Drs. Karli R Hochstatter (PI) and Jan Gryczynski (Co-I), along with the Chief Medical Examiner from the New York City Medical Examiner’s Office, have received an administrative supplement entitled, “Addressing substance use among the social network of suspected drug overdose decedents: rapidly translating epidemiology into prevention intervention science.” This supplement […]
